Hutch News

Conditionally activated immunotherapies alleviate cancer treatment toxicity

Conditionally activated immunotherapies alleviate cancer treatment toxicity

From the Fong Lab, Translational Sciences and Therapeutics
Science SpotlightJune 24, 2025
Fumar o vapear, tóxicos por igual

Fumar o vapear, tóxicos por igual

Laboratorio de Fong, Departamento de Ciencias de Transferencia y de Terapéutica
Science SpotlightFebruary 07, 2025
Cigarettes or vapes, pick your poison

Cigarettes or vapes, pick your poison

From the Fong Lab, Translational Sciences & Therapeutics Division
Science SpotlightDecember 18, 2024
Fred Hutch research shines at national oncology conference

Fred Hutch research shines at national oncology conference

Society for Immunotherapy of Cancer meeting features new discoveries on cancer-cell visualization, T-cell survival and new targets for solid tumors
Hutch NewsDecember 06, 2024
Dr. Lawrence Fong, new Fred Hutch immunotherapy director, talks about how the field has transformed oncology

Dr. Lawrence Fong, new Fred Hutch immunotherapy director, talks about how the field has transformed oncology

In-house grant funding program will underpin efforts to advance therapies to clinical trials
Hutch NewsAugust 15, 2024
Dr. Lawrence Fong to lead Immunotherapy Integrated Research Center

Dr. Lawrence Fong to lead Immunotherapy Integrated Research Center

International expert will help scale up Fred Hutch’s clinical expertise in solid tumor immunotherapy
Hutch NewsOctober 12, 2023